Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

NCT03617341 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03617341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03617341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
October 2, 2018
Completion date
June 3, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer with her2 positive, triple negative breast cancer